Want to see JP:4888 full AI Analyst Report?
STELLA PHARMA CORPORATION (4888) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Bnct, ［18F］Fbpa | Thoracic Solid Malignant Tumor | phase1AndPhase2 | Enrolling By Invitation | Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA | Sep 12, 2024 | ― |
| Bnct | Unresectable Angiosarcoma | Phase II | Active Not Recruiting | A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA | Oct 27, 2022 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Bnct, ［18F］Fbpa | phase1AndPhase2 | Thoracic Solid Malignant Tumor | Enrolling By Invitation | Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA | Sep 12, 2024 | ― |
| Bnct | Phase II | Unresectable Angiosarcoma | Active Not Recruiting | A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA | Oct 27, 2022 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does STELLA PHARMA CORPORATION (JP:4888) have in its pipeline
STELLA PHARMA CORPORATION JP:4888 is currently developing the following drugs: Bnct, ［18F］Fbpa, Bnct. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
